Updates are available Correction dated 2020-07-08
Click to view Correction: https://doi.org/10.1007/s12185-020-02932-8
-
Authors
Henzan, Hideho
Takase, Ken
Kamimura, Tomohiko
Mori, Yasuo
Yoshimoto, Goichi
Iwasaki, Hiromi
Nagafuji, Koji
Ogawa, Ryosuke
Eto, Tetsuya
Uchida, Naoyuki
Fujisaki, Tomoaki
Kato, Koji
Minami, Mariko
Kikushige, Yoshikane
Akashi, Koichi
Miyamoto, Toshihiro https://orcid.org/0000-0002-6533-1594
,
- License Information
-
More Information
Article History
Received: 10 February 2020
Revised: 4 May 2020
Accepted: 27 May 2020
First Online: 10 June 2020
Change Date: 8 July 2020
Change Type: Correction
Change Details: In the original publication of the article, the “CNS involvement” in the last row under the column “Total N=50” has been published incorrectly. The correct Table 1 is given in this correction.
Compliance with ethical standards
:
: KA received grants from Kyowa Hakko Kirin Co., Ltd., Janssen Pharmaceutical K.K., Bristol-Myers Squibb Co., Ltd., Novartis Pharma K.K., Otsuka Pharmaceutical Co., Ltd., MSD Co., Ltd, Astellas Pharmaceutical Co., Ltd., Nippon Shinyaku Co., Ltd., Sumitomo Dainippon Pharmaceutical Co., Ltd., Celgene Co., Ltd., SymBio Pharmaceutical Co., Ltd., Daiichi Sankyo Pharmaceutical Co., Ltd., and Takeda. Pharmaceutical Co., Ltd. K.A., K.N., and T.M. received honoraria from Pfizer Pharmaceutical Co., Ltd. The other authors have no conflicts of interests to declare.
